ASN
HTGM

Advisory Services Network’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Advisory Services Network’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-308
Closed -$21K – 3532
2021
Q2 		$21K Buy
+308
New +$16.7K ﹤0.01% 2487
2021
Q1 		– Sell
-22
Closed -$1K – 3198
2020
Q4 		$1K Buy
+22
New +$1.28K ﹤0.01% 3234

Other funds holding HTGM

CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Advisory Services Network's HTGM Position: Q3 2021 in Review

Advisory Services Network sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2021, closing a stake of 308 shares — an estimated $21K sold.

Advisory Services Network first reported a position in HTGM in Q4 2020 and held it in 2 quarters. The position peaked at $21K in Q2 2021. 23 funds tracked by Wall St. Rank hold HTGM as of Q3 2021.

  • Advisory Services Network reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 308 HTG Molecular Diagnostics, Inc. Common Stock shares in Q3 2021, an estimated $21K.
  • Advisory Services Network first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Advisory Services Network's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $21K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.